Daniel A. Kadin

Daniel Kadin is an intellectual property litigator in the firm's Los Angeles office focusing his practice primarily on patent, trademark, copyright, trade secret and commercial litigation. He has advised plaintiffs and defendants in a wide variety of industries including life sciences, medical device, telecom, software and media before U.S. district and appellate courts. Daniel is also registered to practice before the United States Patent and Trademark Office, and has advised individuals and businesses on patent and trademark prosecution matters, as well as strategic portfolio management.

Daniel has extensive experience conducting pre-litigation analysis, developing litigation strategy, preparing pleadings, motion practice, discovery, depositions, working with experts, and pretrial.

• Moderator, "The Trademark Modernization Act & Best Practices for Trademark Protection and Enforcement," LAIPLA, Mar. 16, 2021
• Presenter, "Licensing 101: Term Sheets and Royalty Modeling," Larta Institute, Aug. 18, 2020

• Co-Author, "SCOTUS Opens the Door for '.com' Trademark Protection in USPTO v. Booking.com," Attorney At Law, July 6, 2020
• Author, "Taking Biosimilars to the Next Level: Why Federalizing the Substitution of Biosimilars Promotes Innovation, Competition, and Patient Safety," 45 Southwestern Law Review 405–432, 2016